The dioxin poisoning of Victor Yushchenko -- methods needed for routine analysis of metabolites of the poison TCDD

August 04, 2009

An Article published Online First ( tracks the science behind the poisoning of Ukrainian President Victor Yushchenko in 2004, and concludes that routine analytical techniques are needed to test for metabolites of TCDD* (the poison used--a type of dioxin)--so that appropriate treatment can be given. The Article is written by Professor Jean Saurat, Swiss Centre for Human Applied Toxicology, and University Hospital, Geneva, Switzerland, and colleagues.

In late December, 2004, Victor Yushchenko presented with TCDD poisoning, indicating a concentration in his blood more than 50,000 times that of the general population. The medical team identified TCDD and its metabolites and monitored their levels for three years using various chemical techniques. Samples of blood, fatty tissue, faeces, skin, urine, and sweat were analysed.

Of the TCDD eliminated during the three years, some 60% of it was in its original form and had not been metabolised. Two metabolites of TCDD were identified in the faeces, blood, and urine. The faeces contained the highest concentration of TCDD metabolites, and were the main route of elimination. Altogether, the different routes of elimination of TCDD and its metabolites accounted for 98% of the loss of the toxin from the body. The half-life (time taken for the amount in the body to halve) of TCDD in Mr Yushchenko was 15 months.

The authors say that of 17 dioxin types analysed in Mr Yushchenko, only TCDD levels were higher than those in the general population, indicating an acute intoxication of pure TCDD. They say: "The highest levels of metabolites were detected in faeces, whereas only traces were found in the blood serum. The metabolite to TCDD ratio was 50-fold lower in the blood serum than in faeces. These findings indicate that these metabolites were unlikely to have been ingested with TCDD, and that TCDD is slowly metabolised, probably by the liver and skin." They add that high concentrations of TCDD might be needed to activate enzymes in the skin responsible for its metabolism, which might explain why the half life of TCDD varies with level of exposure.

The authors conclude: "Although not done previously, levels of TCDD and its metabolites in tissue, faeces, and body fluids should be monitored in a patient with severe dioxin poisoning because they are indicators of what the follow-up period and treatment strategy should be. The poisoning of Victor Yushchenko with TCDD has changed from a story reported in the news to a medical model. This model of TCDD poisoning indicates that methods need to be designed for the routine analysis of TCDD metabolites in human beings, and the main aims of research into TCDD poisoning in the metabolomic era should be the analysis of factors that are involved in the metabolism of this toxin."

Professor Saurat adds: "This is the first medical report in a peer-reviewed journal on the extraordinary case of Victor Yushchenko. The team was confronted in late December 2004 with a patient severely affected with what was likely to be dioxin poisoning. To cope with such a severe and painful disease, with no established specific treatment, we designed a strategy based on an aggressive monitoring of the poison, nature, distribution, and elimination--the subject of this report. We also designed a search for molecular medicine-based solutions to treat the various organs involved--likely to be the subject of future reports."

In an accompanying Comment, Professor Martin McKee, London School of Hygiene and Tropical Medicine, UK, says: "So who poisoned Victor Yushchenko? The obvious suspects are those members of the security service present at the dinner just before he fell ill, yet during the protests in December they and their colleagues gave covert support to Yushchenko, pre-empting a planned crack-down by Interior Ministry troops. Unfortunately for those seeking an answer, there were many people, within Ukraine and outside it, who had a motive. We might never know and, as Sorg and colleagues note, had Yushchenko died at the time, as he might easily have done, we would probably never even have known that he had been poisoned."
Dr Jean Saurat, Swiss Centre for Human Applied Toxicology, and University Hospital, Geneva, Switzerland T) +41 223729422 E)

Professor Martin McKee, London School of Hygiene and Tropical Medicine, UK T) +44 (0)7973 832576 E)

For full Article and Comment see:

Note to editors: *full name for TCDD= 2,3,7,8-tetrachlorodibenzo-p-dioxin


Related Metabolites Articles from Brightsurf:

Identifying compound classes through machine learning
Bioinformaticians at Friedrich Schiller University Jena, Germany together with colleagues from Finland and the USA, have now developed a unique method with which all metabolites in a sample can be taken into account, thus considerably increasing the knowledge gained from examining such molecules.

Detection of PCBs and their metabolites (OH-PCBs) in the fetal brain of a Japanese macaque
This study selected the Japanese macaque (Macaca fuscata) as a model animal for the fetal transfer of OH-PCBs in humans, and revealed OH-PCB concentrations and their relationships in the maternal and fetal brains.

Study tracks human milk nutrients in infant microbiome
A new study in mice helps explain why gut microbiomes of breastfed infants can differ greatly from those of formula-fed infants.

Statistical analyses of plant metabolites allow solid testing of plant defense theories
High-throughput analyses of small substances in Nicotiana attenuata reveal that plants re-organize their metabolism to produce highly-specific defense metabolites after insect attack.

Terpenoids and aromatic compounds from bryophytes and their central nervous system activity
In this article, Agnieszka Ludwiczuk (Medical University of Lublin, Poland) and Yoshinori Asakawa (Tokushima Bunri University, Japan) review the chemistry of the liverworts, mosses, and hornworts.

Leaving its mark: How frailty impacts the blood
Fifteen blood metabolites are key for diagnosing the age-related disorder, frailty, new study finds.

Unlimited potential: Researchers found new ways to generate totipotent-like cells
Totipotency is set to become a key tool for research and future medical applications.

New study provides insight into the mechanisms of blood clots in cancer patients
Researchers have identified a potential new signaling pathway that may help further the understanding of blood clot formation in cancer patients and ultimately help prevent this complication from occurring.

Hormone therapy linked to decrease level of diabetes biomarkers
The Women's Health Initiative (WHI) remains one of the most highly quoted when debating the benefits and risks of hormone therapy.

University of Alberta researchers discover new biomarker for rare autoimmune disease
University of Alberta researchers have identified a unique biological marker that can be used to identify the presence of the rare autoimmune disease myasthenia gravis, predict the course of the disease and identify new, personalized treatments.

Read More: Metabolites News and Metabolites Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to